Assyro AI

FDA Orange Book · active-ingredient family

Goserelin acetate

Goserelin acetate is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:ZOLADEX · NDA 020578

2

Brand (NDA)

0

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · implant

ProductApplicantApplicationTEApproved
ZOLADEXRLDTERSERANDA 020578Jan 11, 1996
ZOLADEXRLDTERSERANDA 019726Dec 29, 1989

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Goserelin acetate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.